Mike Wu

Dr. Mike Wu is a Conjoint Lecturer affiliated with the Faculty of Medicine and Health at the University of Sydney. He holds roles in the Heart Research Institute (HRI) and the Charles Perkins Centre, focusing on translational research in cardiovascular and immunological disorders. His expertise spans immunopharmacology, thrombosis mechanisms, and drug commercialization.

Education:

• Bachelor of Science (2006), First-Class Honors in Biomedical Science (2008), Queensland University
• PhD in Immunopharmacology (2013), University of Queensland
• Graduate Certificate in Research Commercialization (2012), Queensland University

Research Interests: Mike's work centers on clarifying mechanisms of microvascular obstruction in ischemic diseases, particularly the role of dying platelets and endothelial dysfunction in conditions like stroke and SARS-CoV-2 infection. He develops novel anti-coagulants with safer bleeding profiles and diagnostic tools for thrombosis risks.

Key Collaborations:

• Prof. Shaun Jackson (Australian Centre for Blood Diseases, Monash University)
• School of Chemistry, University of Sydney (anti-coagulant drug development)

Funding & Grants:

• Brain Foundation (2019), NHF-Vanguard (2020), MRFF-TTRA (2021), and NHMRC grants
• University of Sydney Kickstart Grant (2017)

Labs/Teams: Leads a biological team under Prof. Jackson’s supervision, collaborating with chemists to advance anti-coagulant therapies and diagnostic platforms.